Efficacy of Oral Colchicine in Prevention of Proliferative Vitreoretinopathy in Rhegmatogenous Retinal Detachment

Shahid Beheshti University of Medical Sciences

Status and phase: Unknown; Phase 3

Conditions: Rhegmatogenous Retinal Detachment

Treatments: Drug: colchicine

Study type: Interventional

Funder types: Other

Identifiers

NCT00370201

8259

Details and patient eligibility

About

This clinical trial will test the efficacy and safety of oral colchicine in prevention of proliferative vitreoretinopathy (PVR) in cases of rhegmatogenous retinal detachment

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Rhegmatogenous retinal detachment

Exclusion criteria

• PVR grade C
• Duration of retinal detachment ≥ one month
• History of cataract surgery
• History of RD surgery

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind